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doi:10.1016/j.jtcvs.2003.12.017TObjective: Extracorporeal lung resection as an alternative to pneumonectomy for
central lung cancer is a procedure in which the unilateral lung is extirpated,
removing the pulmonary lobe with the cancers and replanting the residual pulmo-
nary lobe. The aim of this study was to investigate whether extracorporeal lung
resection for lung cancer can be performed safely.
Methods: Nineteen dogs were divided into the control and extracorporeal lung
resection groups. The former (n  5) underwent lung autotransplantion, and the
latter was subdivided into ND1 (n  7) and ND2 (n  7) groups on the basis of the
manner of lymph node dissection. By comparing the 3 groups, the adverse effects
of lymph node dissection were examined.
Results: All dogs in the control group had no complications. Four dogs in the ND1
group survived for 90 to 630 days after the operation. In the ND2 group 5 dogs
succumbed within 30 days after the operation, although the other 2 dogs survived for
391 and 573 days, respectively. Bronchopulmonary fistulas were seen in 1 of the
ND1 dogs and 3 of the ND2 dogs. Two of the latter were free of thrombus formation
in the pulmonary arteries and veins of the autografts. In the ND2 group, compared
with the control and ND1 group, the tissue blood flow at the bronchial anastomotic
site indicated reduction between the 3rd and 14th postoperative days.
Conclusion: The extensive lymph node dissection had severe adverse effects on
bronchial anastomotic healing in extracorporeal lung resection. Therefore extracor-
poreal lung resection can be applied to only a very limited number of patients with
N0 or N1 disease.
In many developed countries lung cancer has been the leading cause ofcancer death. For non–small cell lung cancer, surgical removal of cancercells is considered the only possible radical treatment. Treatment withpneumonectomy is inappropriate for some patients with dysfunctional lungsbecause this often leads to respiratory failure after the operation. Thefunctional and technical problems often force them to seek other therapeutic
modalities. As an alternative to pneumonectomy, some patients can adapt to extra-
corporeal lung resection (ECLR),1 in which the unilateral lung is extirpated, re-
moving the pulmonary lobe with the cancers and replanting the residual pulmonary
1-3lobe into the body. However, only a few examples of ECLR have been reported,
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tigation required before it can be accepted as an established
treatment.
There are several advantages to ECLR. First, because it
involves autotransplantation, the immunologic system does
not reject the replanted tissue. Additionally, ECLR can be
performed in a favorable visual field without excessive
bleeding because the pulmonary lobe with the cancers can
be removed from the body. With this method, it is easier to
recognize with some consistency the area infiltrated by a
cancerous growth and the condition of the lesions. How-
ever, there are also problems associated with ECLR, includ-
ing the development of bronchopulmonary fistulas
(BPFs).1-3 Unlike conventional lung transplantation, ECLR
for lung cancer requires lymph node dissection. There is a
great need for research into subsequent adverse effects, but
very little has been reported on this subject.
The aim of this study was to investigate whether ECLR
for lung cancer can be performed safely. In this series the
adverse effects of lymph node dissection in ECLR were
evaluated.
Materials and Methods
Animals
Humane care was provided for all dogs in accordance with the
“Guide for the Care and Use of Laboratory Animals” published by
the National Institutes of Health (National Institutes of Health
publication no. 86-23, revised 1985) and the guidelines of the
Japanese Association of Experimental Animals.
Surgical Procedure
Nineteen adult mongrel dogs, each weighing 8.5 to 16 kg (average,
12.9 kg), were premedicated and anesthetized with 0.02 mg/kg
atropine sulfate and 10 mg/kg ketamine hydrochloride. After plac-
ing an instiller in the cubital vein, anesthesia was maintained with
30 mg/kg pentobarbital administered intravenously when neces-
sary. After endotracheal intubation, the dogs were ventilated with
a volume-cycle ventilator to keep the respiratory volume at 25
mL/kg (with unilateral lung ventilation, 15 mL/kg). During the
operation, the fraction of inspiratory oxygen was maintained at
50%. Before and after the operation, antibiotics were administered.
Experimental Protocol
The dogs were divided into control and ECLR groups. The former
(n  5) underwent lung autotransplantion, and the latter were
subdivided into ND1 (n 7) and ND2 (n 7) groups on the basis
of the manner of lymph node dissection. By comparing the 3
groups, the adverse effects of lymph node dissection were exam-
ined. We selected the left lung for autotransplantation and ECLR
because in dogs the right lung consists of 4 lobes and the left lung
consists of 3 lobes. As shown in Figure 1, the configuration of the
left lung provides easier handling for experiments.
Control group. A left posterolateral skin incision was made,
and a thoracotomy was performed. After intravenous injection of
100 U/kg heparin sodium, the left lung was extirpated (Figure 1, A
and B) and then replanted. The left main bronchus was resected at
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bronchi bifurcate. During the extirpation procedure, the left lung
was expanded with a pressure of 15 cm H2O. After Euro-Collins
solution with 2000 U of heparin sodium was perfused through the
pulmonary artery, the lung was preserved for 1 hour. Then the lung
underwent end-to-end anastomosis to the pulmonary vein, bron-
chus, and pulmonary artery. Lymph nodes were not dissected.
ECLR group. The left lung was extirpated by using the same
method as that used in the control group. After Euro-Collins
solution with 2000 U of heparin sodium was perfused through the
pulmonary artery, the lung was divided into the cranial and caudal
lobes (Figure 1, C). After 1 hour of extracorporeal preservation,
the caudal lobe was implanted (Figure 1, D).
Lymph node dissection in the ECLR group. Lymph node
dissection was performed according to Anatomy of the Dog,4
which shows that there are anatomic similarities between human
subjects and dogs in the bronchial blood and lymph supply. The
ND1 group underwent a hilar lymph node dissection. The hilar
lymph nodes (left bronchial lymph nodes) were removed together
with the extirpated lung and dissected when the lungs were sepa-
rated. In the ND2 group systematic hilar and mediastinal lymph
node dissection (cranial mediastinal lymph nodes and left and
middle tracheobronchial lymph nodes, including the surrounding
fatty tissues) was performed. Resection of the mediastinal lymph
nodes was confined to the cranial mediastinal lymph nodes as the
cephalad limit, the pulmonary ligament as the caudal limit, the
thymus as the anterior limit, and the anterior end of the line of the
descending aorta as the posterior limit.
Assessment of autograft. Chest radiographs and broncho-
scopic findings were obtained on the 3rd, 7th, 14th, 21st, and 60th
postoperative days (PODs).
To objectively assess the degree of pulmonary autograft injury
on chest radiographs, we used a semiquantitative scale according
to the method of Aziz and colleagues,5 with scoring as follows: 0,
no abnormal findings; 1, perihilar infiltration; 2, infiltration local-
ized to a limited lung field; 3, diffuse moderate interstitial and
alveolar infiltration; and 4, diffuse severe interstitial and alveolar
infiltration. The 3 groups were compared by using the means of
scores.
To evaluate the anastomotic site healing, we used the classifi-
cation of Couraud and associates,6 with bronchoscopic findings as
follows: grade 1, complete circumferential primary mucosal heal-
ing; grade 2A, complete circumferential healing but partial muco-
sal healing; grade 2B, no mucosal healing; grade 3A, focal necro-
sis; and grade 3B, extensive necrosis.
We used the airway anastomotic index (AAI) to assess the
blood flow at the bronchial anastomotic site. Blood flow of the
bronchial mucosa was measured by using a laser tissue blood
flowmeter (in milliliters per minute per 100 grams; Advans, To-
kyo, Japan) through a bronchoscope. This technique can be useful
for evaluating the effect of bronchial artery revascularization on
mucosal blood flow and can be a prognostically useful tool in
follow-up of bronchial anastomotic healing.7 The measuring sites
were the membranous area very close to the bronchial anastomotic
site of the autograft side and the area of the left main bronchus 2
bronchial rings distal to the tracheal bifurcation. We defined the
former as an anastomotic site and the latter as a control site.
Measurement was conducted 3 times at each site, and the mean
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the anastomotic site to that at the control site in all surviving dogs
over various time periods. This ratio was expressed as the AAI.
We used the relative values because blood flow depends on the
hemodynamic status.
Measurement of PaO2 and pulmonary arterial pressure and
pulmonary angiographic findings. PaO2 and pulmonary arterial
pressure (PAP) were measured before killing the dogs. Pulmonary
angiographs of the lungs were prepared after they were excised
from the killed dogs. On the basis of our findings, we decided
whether the stenosis was located at the anastomotic site of the
pulmonary artery and vein.
Histopathologic analysis. In each group the autografts, includ-
ing the anastomotic sites of the pulmonary artery, vein, and bron-
chus, were extirpated at the time of death. After the lung had been
fixed with a 10% formalin solution, paraffin sections of the anas-
tomotic sites on the pulmonary artery, vein, bronchus, and periph-
eral pulmonary tissue were prepared and subjected to hematoxylin-
eosin staining and Elastica van Gieson staining.
Statistical Analysis
The results of the experiments were expressed as the average score
Figure 1. The scheme of the procedure for ECLR (A-D).
after pneumonectomy. After 1 hour of extracorporeal p
vena cava; Ao, aorta; PA, pulmonary artery; LA, left atriu
pulmonary vein; a, cranial part of cranial lobe of left lu
of left lung. SD. For comparative examination, ischemic time, chest radio-
The Journal of Thoracicgraphic score, AAI, PaO2, and PAP were analyzed by using the
Mann-Whitney U test.
Results
Mean Ischemic Time
The mean ischemic times between extirpation and implan-
tation of the lung were 145  19, 135  31, and 141  26
minutes in the control, ND1, and ND2 groups, respectively.
There was no significant difference among these groups.
Results of the Operation
Postoperative complications, length of survival, and cause
of death (diagnosed after autopsy) for each group are de-
tailed in Table 1. In the control group 4 dogs survived for 57
to 168 days without complications until they were killed.
One dog succumbed to asthenia without an obvious cause.
In the ND1 group 3 dogs died: 1 each from pneumonia,
BPF, and asthenia. The remaining 4 dogs survived for 90 to
630 days. The pulmonary artery and vein of the autograft in
dog 6, which succumbed to BPF, were obstructed by
eft lung was divided into the cranial and caudal lobes
vation, the caudal lobe was implanted. SVC, Superior
, bronchus; SPV, superior pulmonary vein; IPV, inferior
, caudal part of cranial lobe of left lung; c, caudal lobeThe l
reser
m; B
ng; bthrombi. In the ND2 group 1 dog died from pneumonia, 3
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survived for a long period, 1 showed bronchial stenosis
caused by granulation tissue at the anastomotic site. At the
autopsy on the 391st day, the anastomotic site was almost
occluded. The other dog survived for 573 days after the
operation. Analysis of the 3 dogs that succumbed to BPF
showed that the pulmonary artery and vein of the autograft
in dog 4 were obstructed by thrombi. The other 2 dogs were
free of thrombus formation.
Chest Radiograph Score
The mean chest radiograph scores of surviving dogs in each
group over various time periods are shown in Table 2. On
the third and seventh PODs, pulmonary injury was signifi-
cantly more severe in the ND2 group than in the control or
ND1 groups (third POD, P  .05 vs the control and ND1
groups; seventh POD, P .01 vs the control group and P
.02 vs the ND1 group). There were no significant differ-
ences between the control and ND1 groups. One of the ND2
dogs that survived for a long period retained its respiratory
functions until the 60th POD, but its lungs became atelec-
tatic after 1 year.
Grading of Anastomotic Site Healing
In the control group Couraud grading of anastomotic site
healing on the seventh POD was 2A in all dogs. After the
14th POD, all dogs were grade 1. In the ND1 group on the
TABLE 1. Results of the operation
Group
Dog
no.
Survival
(d) BPF
Thrombi
in PV
Bronchial
stenosis
Cause of death
(autopsy)
Control 1 66    Killed
2 18    Asthenia
3 168    Killed
4 57    Killed
5 79    Killed
ND1 1 630    Killed
2 608    Killed
3 12    Pneumonia
4 32    Asthenia
5 90    Killed
6 31    BPF, pyothorax
7 478    Killed
ND2 1 1    Bleeding
2 10    BPF
3 7    Pneumonia
4 16    BPF
5 573    Killed
6 26    BPF
7 391    Killed
BPF, Bronchopulmonary fistula; PV, pulmonary vein; Control, lung auto-
transplantation without lymph node dissection; ND1, extracorporeal lung
resection with hilar lymph node dissection alone; ND2, extracorporeal lung
resection with systematic hilar and mediastinal lymph node dissection.seventh POD, 6 dogs were grade 2A, and 1 dog was grade
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the ND2 group on the seventh POD, 2 dogs were grade 2B,
1 dog was grade 3A, and 2 dogs were grade 3B. Re-
epithelization was barely detectable on the third to seventh
PODs. On the 14th POD, 2 dogs were grade 2A, 1 dog was
grade 3A, and 1 dog was grade 3B. Two dogs that survived
for a long period were grade 1 after the 21st POD. However,
bronchial stenosis gradually developed in dog 7, and the
lesion was almost occluded by granulation tissue after 1
year. Compared with the control and ND1 groups, re-epi-
thelization in the ND2 group was delayed.
Airway Anastomotic Index
Average AAI values of each group over various time peri-
ods are shown in Figure 2. For the control group, the AAI
was 69.5%  10.3% on the third POD but recovered to
82.7%  9.3% on the seventh POD. In the ND1 group the
AAI was 62.6%  9.6% on the third POD and recovered to
80.5%  4.2% on the seventh POD. In the ND2 group the
AAI was markedly reduced on the third POD (31.6% 
9.5%), and remained low on the seventh POD (44.6% 
14.6%). This condition gradually improved to 71.0% 
20.9% and 89.2%  16.1% on the 14th and 21st PODs,
respectively. On the 60th POD, the 3 groups had equal AAI
values. Compared with the control and ND1 groups, the
AAI of the ND2 group was significantly reduced on the
third (P  .0001 vs the control and ND1 groups) and
seventh (P  .001 vs the control and ND1 groups) PODs.
There were no significant differences between the control
and ND1 groups.
Measurement of PaO2 and PAP and Angiographic
Findings
The mean preoperative PaO2 values of the control, ND1, and
ND2 groups were 93.7  5.8 mm Hg, 92.9  5.2 mm Hg,
and 92.7 4.7 mm Hg, respectively. The mean PaO2 values
of the dogs that remained alive for a long period in each
group were 93.3  5.4 mm Hg, 91.0  4.4 mm Hg, and
90.5  4.7 mm Hg, respectively. There were no significant
TABLE 2. Chest radiograph scores
Group
Postoperative time (d)
3rd 7th 14th 21st 60th
Control 1.6 0.5* 1.2 0.4† 0.2 0.4 0.2 0.4 0.0
ND1 1.7 0.5 1.3 1.0 0.7 1.2 0.7 1.6 0.0
ND2 2.3 0.5 2.6 0.5 1.8 0.8 0.7 1.2 0.0
Values are presented as means  SD. See Table 1 for definitions of
groups.
*P  .05, compared with the control group and the ND1 group.
†P .01 compared with the control group; P .02 compared with the ND1
group.differences between the groups before the operation, and
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after the operation within either group.
The right mean PAPs of the control, ND1, and ND2
groups were 13.5  2.2 mm Hg, 12.8  1.8 mm Hg, and
12.6  1.2 mm Hg, respectively. The left mean PAPs were
15.1 3.9 mm Hg, 15.2 2.4 mm Hg, and 16.5 1.7 mm
Hg, respectively. There was a tendency for the left mean
PAP to be slightly higher than the right mean PAP in all
groups.
All dogs that survived for a long time showed fine
arterial and venous conditions. There was no stenosis or
twisting of the pulmonary artery or vein.
Histologic Findings in the Dogs That Survived for a
Long Period
At the bronchial anastomotic sites, the bronchial epithelium
at the anastomotic site was completely re-epithelialized in
all groups.
At the pulmonary arterial and venous anastomotic sites,
in all groups regeneration of the endothelial cells was com-
plete at the anastomotic sites. Dense fibrous cicatricial tissue
had formed around these sites.
At the peripheral pulmonary tissue, the findings were
identical in all groups. Some emphysematous changes were
Figure 2. Changes in AAI: circles, control group; square
of blood flow at the anastomotic site to that at the cont
distal to the tracheal bifurcation) in all surviving dogs
AAI.noted, but the alveolar structure was preserved. There were
The Journal of Thoracicno cases of thickening of the interalveolar septa or inflam-
matory cellular infiltration. The visceral pleura were gener-
ally thickened with fibrous tissue.
Discussion
ECLR, as an alternative to pneumonectomy for patients
with central lung cancer and a dysfunctional lung, was first
reported by Vogt-Moykopf in 1992.1 This radical therapeu-
tic approach to lung cancer helps preserve pulmonary func-
tion. ECLR can be used in cases in which it is difficult to
remove the tumor even by means of pulmonary lobectomy
or sleeve lobectomy. Specifically, the procedure might be
applicable to cases in which the tumor infiltrates the pul-
monary artery and vein or in cases in which it is difficult to
separate the tumor from normal tissues because the tumor is
complicated by a hilar inflammatory disease, such as pul-
monary tuberculosis.
In many reported series8-13 complications and mortalities
of sleeve lobectomy are less severe than those of pneumo-
nectomy. Long-term survival is certainly comparable and in
some reported series10,11 is higher for sleeve lobectomy. It
has been reported that patients who have had pneumonec-
tomy have a higher death rate from non–cancer-related
1 group; triangles, ND2 group. We calculated the ratio
te (the area of the left main bronchus 2 bronchial rings
various time periods. This ratio was expressed as thes, ND
rol si
overcauses. In this respect, by preserving pulmonary function,
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incidence of respiratory failure; ECLR is an advanced
sleeve lobectomy technique.
With ECLR, the immunologic system does not reject the
graft, but there are often complications at the anastomotic
sites, and this increases operative mortality.1-3 There is a
great need to eliminate these problems. In partial lung
transplantation, major causes of complications at the bron-
chial anastomotic site are stenosis and obstruction caused by
thrombus formation at the anastomosed vein.14,15 Stenosis
in the pulmonary vein results in pulmonary edema and
obstruction of the pulmonary artery. During the early period
after an operation, the peripheral bronchus of the bronchial
anastomotic site is nurtured by backflow from the pulmo-
nary artery.16 Thus stenosis at the pulmonary vein often
leads to BPF, as observed in the ND1 and ND2 groups. For
these reasons, special care should be taken to prevent ste-
nosis at the anastomotic site of the pulmonary vein. It might
be necessary to consider systemic anticoagulation treatment
after the operation,17 although anticoagulant was not admin-
istered after the operation in the present study because it is
not usually necessary in autotransplantation models.
ECLR to treat lung cancer must be accompanied by
systematic lymph node dissection, including excision of the
mediastinal lymph nodes. To our knowledge, there have
been no reports that describe how lymph node dissection
influences the bronchial anastomotic site healing in lung
transplantation. From the 3rd to the 14th POD, the tissue
blood flow at the bronchial anastomotic site was lower in
the ND2 group than in the control or ND1 groups. During
this period, in the ND2 group the bronchial anastomotic site
healing was delayed, and the pulmonary injury was severe.
BPF without obstruction in the pulmonary arteries and veins
might be due to the extensive lymph node dissection, lead-
ing to decreased blood flow at the bronchial anastomotic site
and diminished lymphatic flow. At this site, circulation
might become very poor because the microcirculation in the
pulmonary peripheral vessels is further curtailed by post-
transplantation reperfusion injury.18 The present canine
model was not a lung cancer model, and the dogs were not
exposed to the adverse effects of smoking. Although dogs
with healthy lungs were selected, the failure rate was high in
the ND2 group. For patients with low respiratory functions,
complications can lead to death. Therefore ECLR cannot be
applied to a wide range of patients, especially those with N2
disease.
On the other hand, the prognosis of pathologic N2 non–
small cell lung cancer is generally poor. Also, for patients
with N0 or N1 status, survival after sleeve lobectomy is
equal to or better than that of pneumonectomy for a similar-
stage tumor.10 Therefore ECLR should also be used to treat
N0 and N1 non–small cell lung cancers, considering the
factors of lymph node dissection and prognosis. Actual
1348 The Journal of Thoracic and Cardiovascular Surgery ● Maclinical application of ECLR might be limited to localized
central lung cancer, which cannot be treated with pulmonary
lobectomy or sleeve lobectomy, after excluding N2 disease
by means of computed tomography, positron emission to-
mography, or mediastinoscopy.19 However, ECLR might be
indicated for some patients, although probably a very lim-
ited number. Thus we conclude that the technique can be a
useful procedure in certain cases.
The limitation of this study is that we used dogs that
underwent autotransplantation of an entire lung as a control
group. We selected this simple control to evaluate bronchial
anastomotic healing and blood flow at the bronchial anas-
tomotic site in autotransplantation, excluding the technical
and hemodynamic factors in autotransplantation of a pul-
monary lobe. It would be much better for the control group
to comprise dogs that underwent autotransplantation of a
lobe. However, although the ND1 group did not have sig-
nificantly different bronchial healing than the control group,
there were obvious adverse effects in the ND2 group. Ad-
ditionally, the present results raise the following question:
Can using viable tissues to cover the bronchial anastomotic
site improve the blood flow at the bronchial anastomotic
site? Experiments should be designed to investigate whether
such innovative methods can improve the bronchial anas-
tomotic healing.
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